Intellectus Partners LLC Has $4.59 Million Stake in Intuitive Surgical, Inc. $ISRG

Intellectus Partners LLC boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 33.9% in the fourth quarter, HoldingsChannel.com reports. The firm owned 8,108 shares of the medical equipment provider’s stock after buying an additional 2,053 shares during the period. Intuitive Surgical accounts for about 0.9% of Intellectus Partners LLC’s investment portfolio, making the stock its 20th largest holding. Intellectus Partners LLC’s holdings in Intuitive Surgical were worth $4,592,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Riversedge Advisors LLC increased its holdings in Intuitive Surgical by 1.9% in the fourth quarter. Riversedge Advisors LLC now owns 901 shares of the medical equipment provider’s stock valued at $510,000 after purchasing an additional 17 shares during the period. Fiduciary Financial Group LLC increased its holdings in Intuitive Surgical by 2.1% in the fourth quarter. Fiduciary Financial Group LLC now owns 920 shares of the medical equipment provider’s stock valued at $521,000 after purchasing an additional 19 shares during the period. Prosperity Consulting Group LLC increased its holdings in Intuitive Surgical by 0.5% in the third quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider’s stock valued at $1,804,000 after purchasing an additional 19 shares during the period. Sunburst Financial Group LLC increased its holdings in Intuitive Surgical by 4.3% in the fourth quarter. Sunburst Financial Group LLC now owns 485 shares of the medical equipment provider’s stock valued at $275,000 after purchasing an additional 20 shares during the period. Finally, WoodTrust Financial Corp increased its holdings in Intuitive Surgical by 0.5% in the fourth quarter. WoodTrust Financial Corp now owns 4,180 shares of the medical equipment provider’s stock valued at $2,367,000 after purchasing an additional 20 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research firms recently weighed in on ISRG. Robert W. Baird increased their price objective on Intuitive Surgical from $575.00 to $610.00 and gave the company an “outperform” rating in a report on Wednesday, April 22nd. Zacks Research downgraded Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Monday, March 30th. Deutsche Bank Aktiengesellschaft decreased their price target on Intuitive Surgical from $440.00 to $366.00 and set a “sell” rating for the company in a report on Tuesday. Leerink Partners decreased their price target on Intuitive Surgical from $622.00 to $573.00 and set an “outperform” rating for the company in a report on Wednesday, April 22nd. Finally, Piper Sandler reiterated an “overweight” rating and set a $580.00 price target on shares of Intuitive Surgical in a report on Tuesday. Nineteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $573.63.

Key Headlines Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Piper Sandler reiterated its Buy rating on Intuitive Surgical, which helps support the case that Wall Street still sees upside in the company’s robotic surgery franchise. Article Title
• Positive Sentiment: Commentary highlighted Intuitive Surgical’s AI-driven digital roadmap and da Vinci 5 adoption as potential long-term growth drivers, suggesting its robotics ecosystem still has room to expand. Article Title
• Neutral Sentiment: Several articles simply noted that ISRG has been a weak performer recently and raised the question of a rebound; these pieces did not provide a fresh catalyst. Article Title
• Negative Sentiment: Deutsche Bank cut its price target on Intuitive Surgical to $366 from $440 and kept a Sell rating, reinforcing concerns that the shares may still have downside from current levels. Article Title
• Negative Sentiment: SVP Iman Jeddi sold 5,625 shares in a pre-arranged 10b5-1 transaction, which can still weigh on sentiment because it reduces insider ownership and may be viewed cautiously by investors. Article Title
• Negative Sentiment: Market coverage also said ISRG underperformed peers and the broader healthcare group, adding to the narrative that the stock has lost momentum recently. Article Title

Intuitive Surgical Trading Up 1.2%

Shares of Intuitive Surgical stock opened at $407.29 on Thursday. The business has a 50-day moving average price of $449.26 and a two-hundred day moving average price of $502.50. Intuitive Surgical, Inc. has a 1-year low of $396.68 and a 1-year high of $603.88. The company has a market cap of $144.25 billion, a P/E ratio of 49.37, a PEG ratio of 3.21 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. The firm had revenue of $2.77 billion during the quarter, compared to the consensus estimate of $2.62 billion. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The business’s revenue was up 23.0% compared to the same quarter last year. During the same period last year, the business posted $1.81 EPS. Equities research analysts forecast that Intuitive Surgical, Inc. will post 8.57 EPS for the current fiscal year.

Insider Activity at Intuitive Surgical

In other news, EVP Myriam Curet sold 105 shares of the stock in a transaction dated Tuesday, March 10th. The shares were sold at an average price of $493.95, for a total transaction of $51,864.75. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Amy L. Ladd sold 500 shares of the stock in a transaction dated Tuesday, April 28th. The stock was sold at an average price of $473.46, for a total transaction of $236,730.00. Following the transaction, the director directly owned 239 shares in the company, valued at $113,156.94. This trade represents a 67.66% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 7,448 shares of company stock worth $3,224,404. 0.60% of the stock is currently owned by insiders.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.